Per tutti quelli che "ci sono i vaccini, perché il governo ci impone ancora restrizioni!?!"

Fallimento della patente. Tra chi ha incidenti in macchina i patentati sono mille volte più dei non patentati. Però, se fate caso, questo è anche fallimento della scuola. O dell’onestà, dipende dai casi.

Ma è possibile che qualcuno (con tesi stregonesche) possa tenere in scacco il diritto costituzionale alla salute dell’80% degli italiani? Le colonne arancioni di ospedalizzazioni e terapie intensive over 40 (dati ISS al 26.12) urlano che ora veramente BASTA! #ObbligoVaccinale

Stereotactic salvage radioterapy for macroscopic prostate bed recurrence showed comparable BRFS rate and lower tox. If compared to standard treatment. Vanessa,Gabriele Simontacchi,@LpCiccone,Giulia Marvaso,Isacco Desideri,ALESSIO BRUNI link.springer.com/epdf/10.1007/s…

Early results from PSICHE trial showed that macroscopic disease is detected in a significant percentage of patients affected by early BR.Vanessa,@LpCiccone ,Isacco Desideri,Gabriele Simontacchi,#ESTRO2022

The University of Florence, Radiation Oncology Unit crew finally live, again #ESTRO2022 ESTRO Università di Firenze Azienda Ospedaliero-Universitaria Careggi OncoAlert #OncoAlert #wearebackagain #radonc

Have a look! Updates on the APBI-IMRT-Florence trial (NCT02104895) technique: from the IMRT trial to the VMAT clinical practice @LiviaMarrazzo Gabriele Simontacchi (free link for 50 days) #OncoAlert #OncoAlert #radonc #breastcancer authors.elsevier.com/a/1fYf46hRQmoj…

The notion of “probability” is both familiar (we use it), and mysterious (we would typically struggle to define it). Here is a 🧵 to remove the mystery and make the meaning of “probability” more intuitive.

🚨Hot off the press Journal of Clinical Oncology: For decades we have been offering RT omission for early #bcsm patients, here we discuss how tides have changed and its time to omit hormonal therapy and treat with RT instead Alphonse Taghian MGH Breast Oncology Lurie Cancer Center ascopubs.org/doi/abs/10.120…

A true honor having accepted this challenge among great Friends and Colleagues! ESTRO #radonc #medphys #OncoAlert #breastcancer OncoAlert ASTRO Università di Firenze Azienda Ospedaliero-Universitaria Careggi

Quality of Life After radical treatment for MIBc (cistectomy +/-neobladder vs bladder sparing approach): a systematic review #ASCOGU23,Vanessa,Isacco Desideri,Mauro Loi,Gabriele Simontacchi,Icro Meattini d201v5jt9ylckg.cloudfront.net/298/15167/2167…

Apalutamide and SBRT for low-burden, metastatic, hormone-sensitive #ProstateCancer #PERSIAN. Presentation by Giulio Francolini Azienda Ospedaliero-Universitaria Careggi. #GU24 written coverage by Rashid K. Sayyid University of Toronto > bit.ly/3OnrWgf ASCO

(1/4) Check out our latest editorial in @RadiotherapyOn1 Green J, where we dive into the nuances of oligomets! Link: authors.elsevier.com/a/1jtFOcA0-Idni In the clinic, we often describe tumors as indolent vs. rapidly progressing. But we still lack a solid metric to quantify this.

Must read clinical trials in the field of #SBRT 2024 Please complement the list, to allow us staying up-to-date !

Presented at #SABCS24: Interim results from the EUROPA trial: Single-modality #endocrinetherapy vs #radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early #breastcancer thelancet.com/journals/lanon…

Remember the misleading press reports about "brutal" #radonc after PROSPECT ? This is what modern radiotherapy can achieve for elderly breast cancer patients! 👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo" 👉 oncological data awaited

🇵🇸🇮🇱 Comunque la pensiate sul conflitto, lasciare un'intera popolazione assediata senza cibo e aiuti umanitari è un crimine di guerra. A mio parere, uno dei peggiori. Dopo il collasso del cessate il fuoco, da DUE mesi non entra più alcun aiuto nella Striscia. Terribile.

❓ESTRO & EORTC proposed a classification to standardize reirradiation. But does it predict outcomes or toxicity? 🫁☢️ We applied the classification in thoracic reirradiation for NSCLC. Here’s what we found. 🧵

📢 Re-irradiation for prostate cancer relapse after prior radiotherapy is safe,and effective. A study on behalf of Italian association of radiotherapy and clinical oncology (AIRO) 🔬 54-month fup ✅Low rates of severe toxicity 📈 BRFS: 34 months 🔗 doi.org/10.1016/j.rado…